Chapter 5.D.3: In Vitro Fertilization

For more on genetic testing, see Barbara Katz Rothman, The Tentative Pregnancy: Prenatal Diagnosis and the Future of Motherhood (1986); President’s Council on Bioethics, Reproduction and Responsibility: The Regulation of New Biotechnologies (2004); Sonia M. Suter, The Routinization of Prenatal Testing, 28 Am. J. L. & Med. 233 (2002); Jin K. Park & I. Glenn Cohen, The Regulation of Polygenic Risk Scores, 38 Harv. J.L. & Tech. 377 (2024); Jessica L. Roberts & Sonia M. Suter, Damned If You Do or Damned If You Don’t: The Medical Malpractice Implications of Consumer Generated Polygenic Risk Scores, 38 Harv. J.L. & Tech 418 (2024); Dov Fox et al., Choosing Your “Healthiest” Embryo After Dobbs: Polygenic Screening and Distinctive Challenges for Truth in Advertising and Informed Consent, 38 Harv. J.L. & Tech. 463 (2024).

For more on genetic enhancement, see Harry Adams, A Human Germline Modification Scale, 32 J. L. Med. & Ethics 164 (2004); Ronald M. Green, Babies by Design: The Ethics of Genetic Choice (2007); Robert Klitzman, Struggles in Defining and Addressing Requests for “Family Balancing”: Ethical Issues Faced by Providers and Patients, 44 J. L. Med. & Ethics 616 (2016); Jessica Knouse, Reconciling Liberty and Equality in the Debate over Preimplantation Genetic Diagnosis, 2013 Utah L. Rev. 107 (2013); Maxwell J. Mehlman, Any DNA to Declare? Regulating Offshore Access to Genetic Enhancement, 28 Am. J. L. & Med. 179 (2002); Michael Sandel, The Case Against Perfection: Ethics in an Age of Genetic Engineering (2007); Daniel L. Tobey, What’s Really Wrong with Genetic Enhancement: A Second Look at Our Posthuman Future, 6 Yale J. L. & Tech. 54 (2003-2004); and LeRoy Walters & Julie Palmer, The Ethics of Human Gene Therapy (1996).